Earnings summaries and quarterly performance for Ernexa Therapeutics.
Executive leadership at Ernexa Therapeutics.
Board of directors at Ernexa Therapeutics.
Research analysts covering Ernexa Therapeutics.
Recent press releases and 8-K filings for ERNA.
Ernexa Therapeutics Partners with Cellipont Bioservices to Advance ERNA-101
ERNA
New Projects/Investments
Product Launch
- Ernexa Therapeutics (ERNA) has entered into a collaboration with Cellipont Bioservices for Engineering, Differentiation, and Production (EDP) activities.
- The partnership aims to advance ERNA-101, Ernexa's lead cell therapy for the treatment of ovarian cancer, into clinical manufacturing and clinical trials.
- ERNA-101 is designed to activate and regulate the immune system's response to attack cancer cells, with preclinical studies showing its potential to reprogram immunologically "cold" tumors.
Oct 29, 2025, 12:33 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more